Forest Labs Subpoenaed Over New COPD Inhaler
Forest Laboratories Inc. has been targeted by the U.S. Department of Justice in a New York-based probe over its recently released chronic obstructive pulmonary disease treatment Tudorza Pressair, the company revealed...To view the full article, register now.
Already a subscriber? Click here to view full article